C4 Therapeutics, Inc. (CCCC)
4.11
+0.11
(+2.75%)
USD |
NASDAQ |
Aug 24, 16:00
4.07
-0.04
(-0.97%)
After-Hours: 20:00
C4 Therapeutics Total Liabilities (Quarterly) : 112.14M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 112.14M |
| March 31, 2026 | 94.61M |
| December 31, 2025 | 115.35M |
| September 30, 2025 | 111.08M |
| June 30, 2025 | 122.46M |
| March 31, 2025 | 124.38M |
| December 31, 2024 | 133.62M |
| September 30, 2024 | 133.40M |
| June 30, 2024 | 134.04M |
| March 31, 2024 | 140.09M |
| December 31, 2023 | 130.34M |
| September 30, 2023 | 116.99M |
| June 30, 2023 | 141.30M |
| March 31, 2023 | 133.57M |
| Date | Value |
|---|---|
| December 31, 2022 | 141.61M |
| September 30, 2022 | 143.26M |
| June 30, 2022 | 147.88M |
| March 31, 2022 | 150.96M |
| December 31, 2021 | 117.16M |
| September 30, 2021 | 109.13M |
| June 30, 2021 | 111.99M |
| March 31, 2021 | 110.30M |
| December 31, 2020 | 119.35M |
| September 30, 2020 | 128.53M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 119.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | 443.85M |
| Beam Therapeutics, Inc. | 318.91M |
| Rallybio Corp. | 3.567M |
| Q32 Bio, Inc. | 9.962M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 359.40M |
| Shareholders Equity (Quarterly) | 247.26M |
| Debt to Equity Ratio | 0.2299 |
| Current Ratio | 5.449 |
| Net Debt Paydown Yield | 0.26% |